Pharmaceutical composition containing docetaxel
First Claim
1. A pharmaceutical composition containing docetaxel, comprising the pharmaceutical composition includes docetaxel and polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups, wherein the chemical formula of polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups is
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention is a technical filed of pharmaceutical preparation agent, and more particular to a pharmaceutical composition containing docetaxe. The pharmaceutical composition containing docetaxe includes docetaxel and a polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups. The advantage of the present invention is subjected to a tri-block copolymer with low toxicity as the drug carrier. In addition to the pharmaceutical active ingredients and carrier, there is no other additive in pharmaceutical composition containing docetaxe. Thus, the prescription is simpler and the security is higher. In pharmaceutical component containing docetaxel, docetaxel content is more than 20%, such that the preparation process of pharmaceutical component containing docetaxel is simple, and easy for the industrial applications.
4 Citations
5 Claims
- 1. A pharmaceutical composition containing docetaxel, comprising the pharmaceutical composition includes docetaxel and polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups, wherein the chemical formula of polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups is
Specification